DEC 19 , 2007
Selexis Selected as Top Biotech
Download the pdf
NOV 20, 2007
Selexis Announces Promotion of Dr. Pierre-Alain Girod to Chief Scientific Officer
Download the pdf
AUG 21, 2007
Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
Download the pdf
AUG 2, 2007
Selexis Announces License Renewal with Diosynth Biotechnology
Download the pdf
JUL 10, 2007
Selexis Signs Commercial License Agreement with GANYMED Pharmaceuticals
Download the pdf
APR 10, 2007
Selexis Establishes US Subsidiary and Appoints Andrew F. Sandford Vice-President of Business Development and Licensing
Download the pdf
feb 13, 2007
Selexis Expands European Production and Business Operations
New facilities and staff will meet needs of rapidly growing client base, enable continued product innovation
Download the pdf
november 2, 2006
Selexis Receives United States Patent
Patent Covers Methods Used in the Company's SURE Cell Line DevelopmentSM Services and Technology
Download the pdf
July 10, 2006
Selexis to Collaborate with Alpha Biologics on Mammalian Cell Line Development
Alpha Biologics to use Selexis’ SURE Technology Platform to Develop Therapeutic Proteins for Pre-Clinical, Phase I and II Clinical Trials
Download the pdf
June 20 , 2006
Pierre Fabre Enters into License Agreement with Selexis SA to use SURE Technology Platform for Mammalian Cell Line Development
Pierre Fabre Will Use Technology to Research Therapeutic Candidates
Download the pdf
May 30, 2006
Merrimack Pharmaceuticals Enters into License Agreement with Selexis SA to Use SURE Technology Platform for Cell Line Development
Download the pdf
May 23, 2006
Selexis SA Enters Cooperative Agreement with Cambrex Corporation to Use Selexis’ SURE Technology Platform for Mammalian Cell Line Development
Download the pdf
May 5, 2006
Rapid Generation of High Antibody-producer Clones Utilizing Selexis' SURE Technology Platform
Selexis SA to Present at the European Cell Line Development and Engineering Conference
Download the pdf
May 2, 2006
Diosynth Biotechnology Enters into License Agreement with Selexis SA to Use SURE Technology Platform for Commercial Cell Line Development
Download the pdf
April 11, 2006
Selexis SA Enters Into Cooperative Relationship Agreement with Henogen SA
Henogen to Use Selexis Technology Platform for Mammalian Cell Line Development
Download the pdf
March 17, 2006
Selexis SA to Partner at the BIO 2006 Annual International Convention
Selexis to Participate in the Business Forum's One-on-one Partnering Meetings
Download the pdf
February 24, 2006
Case Study Illustrates Cell Specific Productivities of up to 80 pcd Utilizing Bioinformatics and Selexis Patented Technology, MARtech™
Selexis SA to Present Case Study at the Antibody Development and Production Conference
Download the pdf
February 21, 2006
Selexis SA Presented New Data on MARtech™ at the BioProcess International, European Conference and Exhibition
Patented Technology Significantly Improves the Stability of Production Cell Lines
Download the pdf
February 13, 2006
Selexis SA to Present New Data on MARtech™ at the BioProcess International, European Conference and Exhibition
Data Will Elucidate the Mechanism Behind MARtech™
Download the pdf
In order to read this documents you need Acrobat Reader.
If you do not have this software installed, you may download and install it easily and for free clicking here:
